Annual report pursuant to Section 13 and 15(d)


Cover - USD ($)
12 Months Ended
Apr. 30, 2022
Jul. 19, 2022
Oct. 31, 2021
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Apr. 30, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --04-30    
Entity File Number 001-40483    
Entity Registrant Name ALZAMEND NEURO, INC.    
Entity Central Index Key 0001677077    
Entity Tax Identification Number 81-1822909    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 3500 Lenox Rd NE    
Entity Address, Address Line Two Suite 1500    
Entity Address, City or Town Atlanta    
Entity Address, State or Province GA    
Entity Address, Postal Zip Code 30326    
City Area Code 844    
Local Phone Number 722-6333    
Title of 12(b) Security Common Stock, $0.0001 par value per share    
Trading Symbol ALZN    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 109,100,000
Entity Common Stock, Shares Outstanding   95,481,790  
Auditor Firm ID 23    
Auditor Name BAKER TILLY US, LLP    
Auditor Location San Diego, California